US 10398668
Glutamate treatment of cardiovascular disorders
granted A61KA61K31/197A61K33/02
Quick answer
US patent 10398668 (Glutamate treatment of cardiovascular disorders) held by The Board of Regents of the University of Oklahoma expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Oklahoma
- Grant date
- Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/197, A61K33/02, A61K33/06, A61K41/00